APA (7th ed.) Citation

Hideyo, K., Keiko, W., Taro, Y., Keita, M., Akinori, F., Takeshi, K., . . . Hidetomo, M. (2024). Assessment tools and outcomes in real–world migraine patients eligible for treatment with an anti–calcitonin gene–related peptide antibody. 神経治療学, 41(1), 39-48. https://doi.org/10.15082/jsnt.41.1_39

Chicago Style (17th ed.) Citation

Hideyo, Kasai, et al. "Assessment Tools and Outcomes in Real–world Migraine Patients Eligible for Treatment with an Anti–calcitonin Gene–related Peptide Antibody." 神経治療学 41, no. 1 (2024): 39-48. https://doi.org/10.15082/jsnt.41.1_39.

MLA (9th ed.) Citation

Hideyo, Kasai, et al. "Assessment Tools and Outcomes in Real–world Migraine Patients Eligible for Treatment with an Anti–calcitonin Gene–related Peptide Antibody." 神経治療学, vol. 41, no. 1, 2024, pp. 39-48, https://doi.org/10.15082/jsnt.41.1_39.